Kelly Hunter

Kelly Hunter leads the development of Propath’s spatial proteomics and transcriptomics services. He has been involved in the implementation and commercialisation of spatial biology methods, including multiplex imaging single-cell spatial analysis platforms and data analysis pipelines and works with pharmaceutical and biotechnology companies to support translational research, biomarker studies and clinical trial analyses. Specialising in platform development and implementation, Kelly has worked across diagnostic laboratories, academic Core Facility and CRO at the cross section of technology and regulatory compliance.